Assessing the Practical Differences in LDL-C Estimates Calculated by Friedewald, Martin/Hopkins, or NIH Equation 2: An Observation Cross-Sectional Study
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: Low-density lipoprotein-cholesterol (LDL-C) remains a clinically important cholesterol target in primary prevention of atherosclerotic cardiovascular disease. The present study aimed to assess the practical differences among three equations utilized for the estimation of LDL-C: the Friedewald, the Martin/Hopkins, and the NIH equation 2. Methods: Blood lipid measurements from 4,556 noninstitutionalized participants, aged 12 to 80, were obtained from the 2017-2020 National Health and Nutrition Examination Survey study. We 1) assessed the differences between three calculated LDL-C estimates, 2) examined the correlations between LDL-C estimates using correlation coefficients and regression, and 3) investigated the degree of agreement in classifying individuals into the LDL-C category using weighted Kappa and percentage of agreement. Results: The differences in LDL-C estimates between equations varied by sex and triglyceride levels (p<0.001). Overall, the mean of absolute differences between Friedewald and Martin/Hopkins was 3.17 mg/dL (median=2.0, 95% confidence interval [CI] [3.07–3.27]). The mean of absolute differences between Friedewald and NIH Equation 2 was 2.08 mg/dL (median=2.0, 95% CI [2.03–2.14]). Friedewald correlated highly with Martin/Hopkins (r=0.991, rho=0.989) and NIH Equation 2 (r=0.998, rho=0.997). Cohen’s weighted Kappa=0.92 between Friedewald and Martin/Hopkins, and 0.95 between Friedewald and NIH equation 2. The percentage of agreement in classifying individuals into the same LDL-C category was 93.0% between Friedewald and Martin/Hopkins, and 95.4% between Friedewald and NIH equation 2. Conclusion: Understanding the practical differences in LDL-C calculations can be helpful in facilitating decision-making during a paradigm shift.
Abstract
Objective: Low-density lipoprotein-cholesterol (LDL-C) remains a clinically important cholesterol target in primary prevention of atherosclerotic cardiovascular disease. The present study aimed to assess the practical differences among three equations utilized for the estimation of LDL-C: the Friedewald, the Martin/Hopkins, and the NIH equation 2. Methods: Blood lipid measurements from 4,556 noninstitutionalized participants, aged 12 to 80, were obtained from the 2017-2020 National Health and Nutrition Examination Survey study. We 1) assessed the differences between three calculated LDL-C estimates, 2) examined the correlations between LDL-C estimates using correlation coefficients and regression, and 3) investigated the degree of agreement in classifying individuals into the LDL-C category using weighted Kappa and percentage of agreement. Results: The differences in LDL-C estimates between equations varied by sex and triglyceride levels (p<0.001). Overall, the mean of absolute differences between Friedewald and Martin/Hopkins was 3.17 mg/dL (median=2.0, 95% confidence interval [CI] [3.07–3.27]). The mean of absolute differences between Friedewald and NIH Equation 2 was 2.08 mg/dL (median=2.0, 95% CI [2.03–2.14]). Friedewald correlated highly with Martin/Hopkins (r=0.991, rho=0.989) and NIH Equation 2 (r=0.998, rho=0.997). Cohen’s weighted Kappa=0.92 between Friedewald and Martin/Hopkins, and 0.95 between Friedewald and NIH equation 2. The percentage of agreement in classifying individuals into the same LDL-C category was 93.0% between Friedewald and Martin/Hopkins, and 95.4% between Friedewald and NIH equation 2. Conclusion: Understanding the practical differences in LDL-C calculations can be helpful in facilitating decision-making during a paradigm shift.
참고문헌 (44)
- Reiter-Brennan C, "ACC", AHA lipid guidelines : Personalized care to prevent cardiovascular disease, 2020, pp.87, 231~239
- Arnett DK, "2019 ACC", AHA Guideline on the Primary Prevention of Cardiovascular Disease : Executive Summary : A Report of the American College of Cardiology, Circulation, pp.2019, 140[DOI]
- Mach F, "ESC Scientific Document Group. 2019 ESC", EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, 2020, pp.41, 111~188
- Nauck M, "Methods for measurement of LDL-cholesterol : a critical assessment of direct measurement by homogeneous assays versus calculation", Clin Chem, 48, pp.236~254 (2002)
- Friedewald WT, "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge", Clin Chem, 18, pp.499~502 (1972)
- Martin SS, "Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications", J Am Coll Cardiol, 62, pp.732~739 (2013)
- Kannan S, "LDL-cholesterol : Friedewald calculated versus direct measurement-study from a large Indian laboratory database", Indian J Endocrinol Metab, 18, pp.502~504 (2014)
- Scharnagl H, "The Friedewald formula underestimates LDL cholesterol at low concentrations", Clin Chem Lab Med, 39, pp.426~431 (2001)
- Rifai N, "Measurement of low-density-lipoprotein cholesterol in serum : a status report", Clin Chem, 38, pp.150~160 (1992)
- Egbaria A, "Assessment of Low LDL Cholesterol in Patients Treated by PCSK9 Inhibition : Comparison of Martin", Hopkins and Friedewald Estimations, 2021, pp.35, 787~792
- Martin SS, "Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin", Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation : Insights From the FOURIER Trial, 2018, pp.3, 749~753
- de Cordova CM, "A new accurate, simple formula for LDL-cholesterol estimation based on directly measured blood lipids from a large cohort", Ann Clin Biochem, 50, pp.13~19 (2013)
- Dansethakul P, "Determining a new formula for calculating low-density lipoprotein cholesterol : data mining approach", EXCLI J, 14, pp.478~483 (2015)[DOI]
- Rasouli M, "Calculation of LDL-Cholesterol vs. Direct Homogenous Assay", J Clin Lab Anal, 31, pp.e22057~ (2017)
- Vohnout B, "Evaluation of alternative calculation methods for determining LDL cholesterol", Vnitr Lek, 54, pp.961~964 (2008)[DOI]
- Anandaraja S, "Low-density lipoprotein cholesterol estimation by a new formula in Indian population", Int J Cardiol, 102, pp.117~120 (2005)
- Chen Y, "A modified formula for calculating low-density lipoprotein cholesterol values", Lipids Health Dis, 9, pp.52~ (2010)
- Vujovic A, "Evaluation of different formulas for LDL-C calculation", Lipids Health Dis, 9, pp.27~ (2010)
- Gazi IF, "LDL-cholesterol calculation formulas in patients with or without the metabolic syndrome", Int J Cardiol, 119, pp.414~415 (2007)
- Puavilai W, "The accuracy in using modified Friedewald equation to calculate LDL from non-fast triglyceride : a pilot study", J Med Assoc Thai, 92, pp.182~187 (2009)[DOI]
- Hattori Y, "Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol", LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL, 1998, pp.138, 289~299
- Rao A, "Calculation of low-density lipoprotein cholesterol with use of triglyceride", cholesterol ratios in lipoproteins compared with other calculation methods, 1988, pp.34, 2532~2534
- Ahmadi SA, "The impact of low serum triglyceride on LDL-cholesterol estimation", Arch Iran Med, 11, pp.318~321 (2008)[DOI]
- Martin SS, "Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile", JAMA, 310, pp.2061~2068 (2013)
- Sampson M, "A New Equation for Calculation of Low-Density Lipoprotein Cholesterol in Patients With Normolipidemia and", or Hypertriglyceridemia, 2020, pp.5, 540~548
- Ferrinho C, "Applicability of Martin-Hopkins formula and comparison with Friedewald formula for estimated low-density lipoprotein cholesterol in e_COR study population", Rev Port Cardiol(Engl Ed), 40, pp.715~724 (2021)
- Naser A, "Comparison of Novel Martin", Hopkins and Sampson Equations for Calculation of Low-Density Lipoprotein Cholesterol in Diabetic Patients, 2022, pp.119, 225~233
- Ertürk Zararsız G, "Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations", PLoS One, 17, pp.e0263860~ (2022)
- Briers PJ, "Concordance of apolipoprotein B concentration with the Friedewald, Martin-Hopkins, and Sampson formulas for calculating LDL cholesterol", Biochem Med (Zagreb), 32, pp.010704~ (2022)
- Dintshi M, "Comparison of measured LDL cholesterol with calculated LDL-cholesterol using the Friedewald and Martin-Hopkins formulae in diabetic adults at Charlotte Maxeke Johannesburg Academic Hospital", NHLS Laboratory, 2022, pp.17, e0277981~
- Cartier LJ, "Impact of the Martin", Hopkins modified equation for estimating LDL-C on lipid target attainment in a high risk patient population, 2020, pp.76, 35~37
- Reiber I, "Comparison of low-density lipoprotein cholesterol level calculated using the modified Martin", Hopkins estimation or the Friedewald formula with direct homogeneous assay measured low-density lipoprotein cholesterol, 2020, pp.18, 577~586
- Steyn N, "Comparability of calculated LDL-C with directly measured LDL-C in selected paediatric and adult cohorts", Clin Chim Acta, 537, pp.158~166 (2022)
- Rossouw HM, "Comparability of 11 different equations for estimating LDL cholesterol on different analysers", Clin Chem Lab Med, 59, pp.1930~1943 (2021)
- Shi B, "Comparison of Estimated LDL Cholesterol Equations with Direct Measurement in Patients with Angiographically Confirmed Coronary Artery Disease", J Cardiovasc Dev Dis, 9, pp.342~ (2022)
- Sajja A, "Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels", JAMA Netw Open, 4, pp.e2128817~ (2021)
- Higgins V, "Validating the NIH LDL-C equation in a specialized lipid cohort : Does it add up?", Clin Biochem, 99, pp.60~68 (2022)
- Ginsberg HN, "LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification : pooled alirocumab trials", J Lipid Res, 63, pp.100148~ (2022)
- Evans NJ, "Assessing the practical differences between model selection methods in inferences about choice response time tasks", Psychon Bull Rev, 26, pp.1070~1098 (2019)
- Meani D, "Practical differences between luteinizing hormone-releasing hormone agonists in prostate cancer : perspectives across the spectrum of care", Ther Adv Urol, 10, pp.51~63 (2017)
- Mora S, "Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27, 331 women", Clin Chem, 55, pp.888~894 (2009)
- Dinç Asarcıklı L, "CVSCORE-TR investigators. Usefulness of novel Martin", Hopkins and Sampson equations over Friedewald equation in cardiology outpatients: A CVSCORE-TR substudy, 2021, pp.75, e14090~
- Ghayad JP, "A Tale of Two Approaches", Am J Clin Pathol, 157, pp.345~352 (2022)
- Martins J, "Best practice for LDL-cholesterol : when and how to calculate", J Clin Pathol, 76, pp.145~152 (2023)